Emilie A. C. Dronkers

A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency

Simone Punt, Emilie A. C. Dronkers, Marij J.P. Welters et al. · Cancer Immunology Immunotherapy · 2016 · 100 citations · Full text

Life Sciences, Immunology, Oncology +17

Noncompliance to guidelines in head and neck cancer treatment; associated factors for both patient and physician

Emilie A. C. Dronkers, Steven W. Mes, Marjan H. Wieringa et al. · BMC Cancer · 2015 · 73 citations · Full text

Medicine, Oncology, Cancer Control +8

Keys to successful implementation of routine symptom monitoring in head and neck oncology with “<scp>Healthcare Monitor</scp>” and patients' perspectives of quality of care

Emilie A. C. Dronkers, Robert J. Baatenburg de Jong, Egge F. van der Poel et al. · Head & Neck · 2020 · 67 citations · Full text

Nursing, Health Administration, Health Informatics +17

Head and neck cancer patients’ preferences for individualized prognostic information: a focus group study

Arta Hoesseini, Emilie A. C. Dronkers, Aniel Sewnaik et al. · BMC Cancer · 2020 · 50 citations · Full text

Medicine, Oncology, Oncology Patient Education +15

Influence of anemia and BMI on prognosis of laryngeal squamous cell carcinoma: Development of an updated prognostic model

Roderick J.L.M. te Riele, Emilie A. C. Dronkers, Marjan H. Wieringa et al. · Oral Oncology · 2018 · 45 citations

Medicine, Hematology, Oncology +11